☰
×
ISI | Contact Us
Home | Key Features | MRI Access | Unmatched Support

Broad MRI Access1

Offer your patients broad access to MRI

The Axonics SNM Systems are Now Approved for Broader MRI Conditional Labeling

DID YOU KNOW...

Legacy devices have clinically shown high rates of impedance issues (18.6%) which can result in loss of efficacy and surgical revisions.2

Axonics Provides a Durable Tined Lead for Reliable Therapy
Axonics tined leads are durable and shown in our clinical studies and commercial patient experience to deliver low rates of open impedances and lead migrations.

rate of open impedances across all commercially implanted patients3

suspected lead migration4

References:

  1. Under certain conditions. For more information visit www.axonics.com/mri. Axonics MRI Guidelines 110-0092-001rAK
  2. Fascelli M, Rueb J, Derisavifard S, et al. Mp31-06 Prevalence of Abnormal Impedance in Sacral Neuromodulation Device and Implication for Practice. J Urol 2020;203 (Supplement 4): e476-e477.
  3. Company data on file 105-0139
  4. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021;40(2):714-721. doi:10.1002/nau.24615

© 2024 Axonics, Inc. All rights reserved. 110-0378-001rA 06/2024
This material contains registered trademarks, trade names, and brand names of Axonics, Inc.